AstraZeneca–HUTCHMED FDA Filing | Lucid Diligence Brief
This Lucid Diligence Brief explores AstraZeneca’s ORPATHYS and TAGRISSO FDA…
WCLC 2026 Preview: Emerging Lung Cancer Therapies and Competitive Trends
WCLC 2026 at a glance At IASLC-WCLC 2026, where will the next wave of…
AI in Healthcare and Digital Health Today—June 23, 2026
This week’s AI in Healthcare and Digital Health update highlights…
AI in Healthcare and Digital Health Today—June 15, 2026
This week’s AI in Healthcare and Digital Health update highlights…
GSK Acquires Nuvalent to Expand Oncology Pipeline | Lucid Diligence Brief
GSK strengthens its oncology portfolio with Nuvalent acquisition, adding…
ELCC 2026 Preview: Key Competitive Shifts in Lung Cancer
ELCC 2026 at a glance ELCC 2026 highlights key lung cancer treatment trends,…
Lucid Diligence Brief: Dizal announces Zegfrovy (sunvozertinib) positive results in EGFR Exon20ins NSCLC
Lucid Diligence Brief: Dizal announces Zegfrovy (sunvozertinib) positive…
Oncology Today—January 26, 2026
This week's Oncology update spans regulatory milestones, late-stage clinical…
Vaccines Today—November 28, 2025
This week’s vaccine report covers major developments, pipeline progress, and…
ERS 2025 Preview: Key Respiratory Highlights to Watch
ERS 2025 at a glance Ahead of ERS 2025 in Amsterdam, get concise highlights…
Public Health Weekly News - September 12th 2025
Public Health Updates: Childhood Obesity, Chronic Disease Trends, And Cannabis…
Oncology Weekly News - September 8th 2025
🔬🧬 Oncology Updates: Tagrisso survival boost, J&J combo win and More…